Related Experiment Video
Updated: Feb 16, 2026

07:06
Particle Agglutination Method for Poliovirus Identification
Published on: April 20, 2011
15.9K
Models and analyses to understand threats to polio eradication.
1Deparment of Epidemiology, 1415 E. Washington Heights, Ann Arbor, MI, 48109, USA. jkoopman@umich.edu.
BMC Medicine
|December 23, 2017
Summary
Phasing out oral poliovirus vaccine (OPV) requires new models to address unknown threats. Research shows a rising risk of vaccine-derived poliovirus spread after OPV cessation, necessitating advanced data analysis.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Vaccinology
Background:
- Complete polio eradication necessitates phasing out the live oral poliovirus vaccine (OPV) post-wild poliovirus transmission.
- Stopping OPV use may introduce poorly understood threats, requiring improved predictive models.
- Existing statistical models may not fully address the complexities of OPV cessation risks.
Purpose of the Study:
- To evaluate the risks associated with oral poliovirus vaccine (OPV) cessation.
- To explore the emergence and transmission of vaccine-derived poliovirus after OPV withdrawal.
- To identify the need for advanced modeling and data sharing for polio eradication.
Main Methods:
- Analysis of polio case data and characteristics in Pakistan using statistical modeling (Mercer et al.).
- Exploration of serotype 2 circulating vaccine-derived poliovirus (cVDPV2) emergence post-OPV2 cessation (McCarthy et al.).
- Assessment of cVDPV2 transmission risks in the years following OPV2 cessation.
Main Results:
- Statistical models can inform resource allocation but may not fully address OPV cessation threats.
- The risk of persistent cVDPV2 spread increases significantly 1-5 years after OPV2 cessation.
- Advanced modeling and readily available datasets are crucial for managing post-cessation risks.
Conclusions:
- New models and analysis methods are essential for overcoming threats posed by OPV cessation.
- The risk of vaccine-derived poliovirus spread necessitates careful monitoring and strategic planning.
- Enhanced data sharing and 'big data' approaches are vital for successful polio eradication efforts.
Related Concept Videos
Steps in Outbreak Investigation
610
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
610
Principles of Disease Surveillance
591
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
591
Models of Health Promotion and Illness Prevention II
2.2K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
The agent-host-environment model states that disease results...
2.2K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
17
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
17
Pharmacodynamic Models: Overview
19
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
19

